- Home
- LNTH vs KLAR Comparison
LNTH vs KLAR Comparison
Compare LNTH & KLAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LNTH | KLAR |
|---|---|---|
| Founded | 1956 | 2005 |
| Country | United States | United Kingdom |
| Employees | N/A | 2831 |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 4.6B |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | LNTH | KLAR |
|---|---|---|
| Price | $76.10 | $13.35 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 15 |
| Target Price | ★ $83.20 | $39.57 |
| AVG Volume (30 Days) | 958.1K | ★ 6.2M |
| Earning Date | 05-06-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.41 | N/A |
| Revenue | ★ $343,374,000.00 | N/A |
| Revenue This Year | N/A | $28.78 |
| Revenue Next Year | $13.93 | $19.96 |
| P/E Ratio | $22.31 | ★ N/A |
| Revenue Growth | ★ 3.62 | N/A |
| 52 Week Low | $47.27 | $12.06 |
| 52 Week High | $108.86 | $47.48 |
Technical Indicators
Market Signals| Indicator | LNTH | KLAR |
|---|---|---|
| Relative Strength Index (RSI) | 51.22 | 42.13 |
| Support Level | $72.33 | $12.50 |
| Resistance Level | $84.77 | $16.78 |
| Average True Range (ATR) | 2.47 | 0.83 |
| MACD | -0.58 | 0.25 |
| Stochastic Oscillator | 40.96 | 32.99 |
Price Performance
Historical ComparisonAbout LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About KLAR Klarna Group plc Ordinary Shares
Klarna Group PLC is a technology-driven payments company, with operations spanning multiple countries. It connects consumers and merchants with comprehensive payment solutions and tailored advertising solutions, both online and offline. Its payment solutions provide consumers with more control and flexibility over their payments. It is a digital bank and flexible payments provider building the next-generation AI-powered commerce network.